New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Exact Sciences Corporation
EXAS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

13B

Medical - Diagnostics & Research

Next Earning date - 05 Nov 2024

13B

Medical - Diagnostics & Research

Next Earning date - 05 Nov 2024

69.11USD
Shape-1.15 ( -1.64%)
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-66%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated October 28, 2024
1W -2.08 % 1M 1.45 % 3M 51.69 % 1Y 17.02 %

Key Metrics

Shape
  • Market Cap

    12.77B


  • Shares Outstanding

    184.77M


  • Share in Float

    181.98M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    69.11


  • Average Volume

    2.39M


  • Beta

    1.273


  • Range

    40.62-79.62


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.exactsciences.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.89x

P/S Ratio

3.99x

P/B Ratio

0.8

Debt/Equity

-6.7%

Net Margin

$-0.9

EPS

How EXAS compares to sector?

P/E Ratio

Relative Strength

Shape

EXAS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape361%

2025-Revenue

$0.01

Shape85%

2025-EPS

$783M

Shape-2619%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Equal-Weight

2024-08-27

Now: Overweight

Scotiabank

initialise

Previous: Outperform

2024-06-26

Now: Sector Outperform

Scotiabank

initialise

Previous: Not converted

2024-06-26

Now: Outperform

Wedbush

initialise

Previous: Not converted

2023-10-10

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.84
vs -0.97

Q4.22

arrow
arrow

N/A

-0.72
vs -1.28

Q1.23

arrow
arrow

N/A

-0.42
vs -1.04

Q2.23

arrow
arrow

N/A

-0.45
vs -0.94

Q3.23

arrow
arrow

+101%

0
vs -0.84

Q4.23

arrow
arrow

N/A

-0.27
vs -0.72

Q1.24

arrow
arrow

N/A

-0.50
vs -0.42

Q2.24

arrow
arrow

N/A

-0.09
vs -0.45

Q3.24

arrow
arrow

N/A

-0.20
vs 0

Q4.24

arrow
arrow

N/A

-0.07
vs -0.27

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+15%

523.1M  vs 456.4M

Q4.22

arrow
arrow

+17%

553M  vs 473.8M

Q1.23

arrow
arrow

+24%

602.5M  vs 486.6M

Q2.23

arrow
arrow

+19%

622.1M  vs 521.6M

Q3.23

arrow
arrow

+20%

628.3M  vs 523.1M

Q4.23

arrow
arrow

+17%

646.9M  vs 553M

Q1.24

arrow
arrow

+6%

637.5M  vs 602.5M

Q2.24

arrow
arrow

+12%

699.3M  vs 622.1M

Q3.24

arrow
arrow

+14%

716.8M  vs 628.3M

Q4.24

arrow
arrow

+20%

778.1M  vs 646.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.05

Q4.22

arrow
arrow

-4%

-0.04
vs -0.05

Q1.23

arrow
arrow

-2%

-0.02
vs -0.04

Q2.23

arrow
arrow

-3%

-0.03
vs -0.02

Q3.23

arrow
arrow

+0%

0
vs -0.03

Q4.23

arrow
arrow

-2%

-0.02
vs 0

Q1.24

arrow
arrow

-4%

-0.04
vs -0.02

Q2.24

arrow
arrow

0%

-0.00
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

494

494
vs 517

-4%

Q4.22

arrow
arrow

573

573
vs 494

16%

Q1.23

arrow
arrow

599

599
vs 573

5%

Q2.23

arrow
arrow

668

668
vs 599

12%

Q3.23

arrow
arrow

642

642
vs 668

-4%

Q4.23

arrow
arrow

667

667
vs 642

4%

Q1.24

arrow
arrow

666

666
vs 667

0%

Q2.24

arrow
arrow

560

560
vs 666

-16%

Earnings Growth

Latest News